Comparison of Manual and Semi-Automatic [18F]PSMA-1007 PET Based Contouring Techniques for Intraprostatic Tumor Delineation in Patients With Primary Prostate Cancer and Validation With Histopathology as Standard of Reference
PurposeAccurate contouring of intraprostatic gross tumor volume (GTV) is pivotal for successful delivery of focal therapies and for biopsy guidance in patients with primary prostate cancer (PCa). Contouring of GTVs, using 18-Fluor labeled tracer prostate specific membrane antigen positron emission t...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-12-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2020.600690/full |
id |
doaj-24f3f41a699c48f2bf7fa91b21ab40c4 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Simon K. B. Spohn Simon K. B. Spohn Maria Kramer Selina Kiefer Peter Bronsert August Sigle Wolfgang Schultze-Seemann Cordula A. Jilg Tanja Sprave Tanja Sprave Lara Ceci Thomas F. Fassbender Nils H. Nicolay Nils H. Nicolay Juri Ruf Anca L. Grosu Anca L. Grosu Constantinos Zamboglou Constantinos Zamboglou Constantinos Zamboglou |
spellingShingle |
Simon K. B. Spohn Simon K. B. Spohn Maria Kramer Selina Kiefer Peter Bronsert August Sigle Wolfgang Schultze-Seemann Cordula A. Jilg Tanja Sprave Tanja Sprave Lara Ceci Thomas F. Fassbender Nils H. Nicolay Nils H. Nicolay Juri Ruf Anca L. Grosu Anca L. Grosu Constantinos Zamboglou Constantinos Zamboglou Constantinos Zamboglou Comparison of Manual and Semi-Automatic [18F]PSMA-1007 PET Based Contouring Techniques for Intraprostatic Tumor Delineation in Patients With Primary Prostate Cancer and Validation With Histopathology as Standard of Reference Frontiers in Oncology primary prostate cancer focal therapy contouring PSMA-PET/CT histopathology |
author_facet |
Simon K. B. Spohn Simon K. B. Spohn Maria Kramer Selina Kiefer Peter Bronsert August Sigle Wolfgang Schultze-Seemann Cordula A. Jilg Tanja Sprave Tanja Sprave Lara Ceci Thomas F. Fassbender Nils H. Nicolay Nils H. Nicolay Juri Ruf Anca L. Grosu Anca L. Grosu Constantinos Zamboglou Constantinos Zamboglou Constantinos Zamboglou |
author_sort |
Simon K. B. Spohn |
title |
Comparison of Manual and Semi-Automatic [18F]PSMA-1007 PET Based Contouring Techniques for Intraprostatic Tumor Delineation in Patients With Primary Prostate Cancer and Validation With Histopathology as Standard of Reference |
title_short |
Comparison of Manual and Semi-Automatic [18F]PSMA-1007 PET Based Contouring Techniques for Intraprostatic Tumor Delineation in Patients With Primary Prostate Cancer and Validation With Histopathology as Standard of Reference |
title_full |
Comparison of Manual and Semi-Automatic [18F]PSMA-1007 PET Based Contouring Techniques for Intraprostatic Tumor Delineation in Patients With Primary Prostate Cancer and Validation With Histopathology as Standard of Reference |
title_fullStr |
Comparison of Manual and Semi-Automatic [18F]PSMA-1007 PET Based Contouring Techniques for Intraprostatic Tumor Delineation in Patients With Primary Prostate Cancer and Validation With Histopathology as Standard of Reference |
title_full_unstemmed |
Comparison of Manual and Semi-Automatic [18F]PSMA-1007 PET Based Contouring Techniques for Intraprostatic Tumor Delineation in Patients With Primary Prostate Cancer and Validation With Histopathology as Standard of Reference |
title_sort |
comparison of manual and semi-automatic [18f]psma-1007 pet based contouring techniques for intraprostatic tumor delineation in patients with primary prostate cancer and validation with histopathology as standard of reference |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Oncology |
issn |
2234-943X |
publishDate |
2020-12-01 |
description |
PurposeAccurate contouring of intraprostatic gross tumor volume (GTV) is pivotal for successful delivery of focal therapies and for biopsy guidance in patients with primary prostate cancer (PCa). Contouring of GTVs, using 18-Fluor labeled tracer prostate specific membrane antigen positron emission tomography ([18F]PSMA-1007/PET) has not been examined yet.Patients and MethodsTen Patients with primary PCa who underwent [18F]PSMA-1007 PET followed by radical prostatectomy were prospectively enrolled. Coregistered histopathological gross tumor volume (GTV-Histo) was used as standard of reference. PSMA-PET images were contoured on two ways: (1) manual contouring with PET scaling SUVmin-max: 0–10 was performed by three teams with different levels of experience. Team 1 repeated contouring at a different time point, resulting in n = 4 manual contours. (2) Semi-automatic contouring approaches using SUVmax thresholds of 20–50% were performed. Interobserver agreement was assessed for manual contouring by calculating the Dice Similarity Coefficient (DSC) and for all approaches sensitivity, specificity were calculated by dividing the prostate in each CT slice into four equal quadrants under consideration of histopathology as standard of reference.ResultsManual contouring yielded an excellent interobserver agreement with a median DSC of 0.90 (range 0.87–0.94). Volumes derived from scaling SUVmin-max 0–10 showed no statistically significant difference from GTV-Histo and high sensitivities (median 87%, range 84–90%) and specificities (median 96%, range 96–100%). GTVs using semi-automatic segmentation applying a threshold of 20–40% of SUVmax showed no significant difference in absolute volumes to GTV-Histo, GTV-SUV50% was significantly smaller. Best performing semi-automatic contour (GTV-SUV20%) achieved high sensitivity (median 93%) and specificity (median 96%). There was no statistically significant difference to SUVmin-max 0–10.ConclusionManual contouring with PET scaling SUVmin-max 0–10 and semi-automatic contouring applying a threshold of 20% of SUVmax achieved high sensitivities and very high specificities and are recommended for [18F]PSMA-1007 PET based focal therapy approaches. Providing high specificities, semi-automatic approaches applying thresholds of 30–40% of SUVmax are recommend for biopsy guidance. |
topic |
primary prostate cancer focal therapy contouring PSMA-PET/CT histopathology |
url |
https://www.frontiersin.org/articles/10.3389/fonc.2020.600690/full |
work_keys_str_mv |
AT simonkbspohn comparisonofmanualandsemiautomatic18fpsma1007petbasedcontouringtechniquesforintraprostatictumordelineationinpatientswithprimaryprostatecancerandvalidationwithhistopathologyasstandardofreference AT simonkbspohn comparisonofmanualandsemiautomatic18fpsma1007petbasedcontouringtechniquesforintraprostatictumordelineationinpatientswithprimaryprostatecancerandvalidationwithhistopathologyasstandardofreference AT mariakramer comparisonofmanualandsemiautomatic18fpsma1007petbasedcontouringtechniquesforintraprostatictumordelineationinpatientswithprimaryprostatecancerandvalidationwithhistopathologyasstandardofreference AT selinakiefer comparisonofmanualandsemiautomatic18fpsma1007petbasedcontouringtechniquesforintraprostatictumordelineationinpatientswithprimaryprostatecancerandvalidationwithhistopathologyasstandardofreference AT peterbronsert comparisonofmanualandsemiautomatic18fpsma1007petbasedcontouringtechniquesforintraprostatictumordelineationinpatientswithprimaryprostatecancerandvalidationwithhistopathologyasstandardofreference AT augustsigle comparisonofmanualandsemiautomatic18fpsma1007petbasedcontouringtechniquesforintraprostatictumordelineationinpatientswithprimaryprostatecancerandvalidationwithhistopathologyasstandardofreference AT wolfgangschultzeseemann comparisonofmanualandsemiautomatic18fpsma1007petbasedcontouringtechniquesforintraprostatictumordelineationinpatientswithprimaryprostatecancerandvalidationwithhistopathologyasstandardofreference AT cordulaajilg comparisonofmanualandsemiautomatic18fpsma1007petbasedcontouringtechniquesforintraprostatictumordelineationinpatientswithprimaryprostatecancerandvalidationwithhistopathologyasstandardofreference AT tanjasprave comparisonofmanualandsemiautomatic18fpsma1007petbasedcontouringtechniquesforintraprostatictumordelineationinpatientswithprimaryprostatecancerandvalidationwithhistopathologyasstandardofreference AT tanjasprave comparisonofmanualandsemiautomatic18fpsma1007petbasedcontouringtechniquesforintraprostatictumordelineationinpatientswithprimaryprostatecancerandvalidationwithhistopathologyasstandardofreference AT laraceci comparisonofmanualandsemiautomatic18fpsma1007petbasedcontouringtechniquesforintraprostatictumordelineationinpatientswithprimaryprostatecancerandvalidationwithhistopathologyasstandardofreference AT thomasffassbender comparisonofmanualandsemiautomatic18fpsma1007petbasedcontouringtechniquesforintraprostatictumordelineationinpatientswithprimaryprostatecancerandvalidationwithhistopathologyasstandardofreference AT nilshnicolay comparisonofmanualandsemiautomatic18fpsma1007petbasedcontouringtechniquesforintraprostatictumordelineationinpatientswithprimaryprostatecancerandvalidationwithhistopathologyasstandardofreference AT nilshnicolay comparisonofmanualandsemiautomatic18fpsma1007petbasedcontouringtechniquesforintraprostatictumordelineationinpatientswithprimaryprostatecancerandvalidationwithhistopathologyasstandardofreference AT juriruf comparisonofmanualandsemiautomatic18fpsma1007petbasedcontouringtechniquesforintraprostatictumordelineationinpatientswithprimaryprostatecancerandvalidationwithhistopathologyasstandardofreference AT ancalgrosu comparisonofmanualandsemiautomatic18fpsma1007petbasedcontouringtechniquesforintraprostatictumordelineationinpatientswithprimaryprostatecancerandvalidationwithhistopathologyasstandardofreference AT ancalgrosu comparisonofmanualandsemiautomatic18fpsma1007petbasedcontouringtechniquesforintraprostatictumordelineationinpatientswithprimaryprostatecancerandvalidationwithhistopathologyasstandardofreference AT constantinoszamboglou comparisonofmanualandsemiautomatic18fpsma1007petbasedcontouringtechniquesforintraprostatictumordelineationinpatientswithprimaryprostatecancerandvalidationwithhistopathologyasstandardofreference AT constantinoszamboglou comparisonofmanualandsemiautomatic18fpsma1007petbasedcontouringtechniquesforintraprostatictumordelineationinpatientswithprimaryprostatecancerandvalidationwithhistopathologyasstandardofreference AT constantinoszamboglou comparisonofmanualandsemiautomatic18fpsma1007petbasedcontouringtechniquesforintraprostatictumordelineationinpatientswithprimaryprostatecancerandvalidationwithhistopathologyasstandardofreference |
_version_ |
1724390931653722112 |
spelling |
doaj-24f3f41a699c48f2bf7fa91b21ab40c42020-12-08T08:33:48ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2020-12-011010.3389/fonc.2020.600690600690Comparison of Manual and Semi-Automatic [18F]PSMA-1007 PET Based Contouring Techniques for Intraprostatic Tumor Delineation in Patients With Primary Prostate Cancer and Validation With Histopathology as Standard of ReferenceSimon K. B. Spohn0Simon K. B. Spohn1Maria Kramer2Selina Kiefer3Peter Bronsert4August Sigle5Wolfgang Schultze-Seemann6Cordula A. Jilg7Tanja Sprave8Tanja Sprave9Lara Ceci10Thomas F. Fassbender11Nils H. Nicolay12Nils H. Nicolay13Juri Ruf14Anca L. Grosu15Anca L. Grosu16Constantinos Zamboglou17Constantinos Zamboglou18Constantinos Zamboglou19Department of Radiation Oncology, Medical Center–University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, GermanyGerman Cancer Consortium (DKTK), Partner Site Freiburg, Freiburg, GermanyDepartment of Radiation Oncology, Medical Center–University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, GermanyInstitute for Surgical Pathology, Medical Center–University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, GermanyInstitute for Surgical Pathology, Medical Center–University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, GermanyDepartment of Urology, Medical Center–University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, GermanyDepartment of Urology, Medical Center–University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, GermanyDepartment of Urology, Medical Center–University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, GermanyDepartment of Radiation Oncology, Medical Center–University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, GermanyGerman Cancer Consortium (DKTK), Partner Site Freiburg, Freiburg, GermanyDepartment of Radiation Oncology, Medical Center–University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, GermanyDepartment of Nuclear Medicine, Medical Center–University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, GermanyDepartment of Radiation Oncology, Medical Center–University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, GermanyGerman Cancer Consortium (DKTK), Partner Site Freiburg, Freiburg, GermanyDepartment of Nuclear Medicine, Medical Center–University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, GermanyDepartment of Radiation Oncology, Medical Center–University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, GermanyGerman Cancer Consortium (DKTK), Partner Site Freiburg, Freiburg, GermanyDepartment of Radiation Oncology, Medical Center–University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, GermanyGerman Cancer Consortium (DKTK), Partner Site Freiburg, Freiburg, GermanyBerta-Ottenstein-Programme, Faculty of Medicine, University of Freiburg, Freiburg, GermanyPurposeAccurate contouring of intraprostatic gross tumor volume (GTV) is pivotal for successful delivery of focal therapies and for biopsy guidance in patients with primary prostate cancer (PCa). Contouring of GTVs, using 18-Fluor labeled tracer prostate specific membrane antigen positron emission tomography ([18F]PSMA-1007/PET) has not been examined yet.Patients and MethodsTen Patients with primary PCa who underwent [18F]PSMA-1007 PET followed by radical prostatectomy were prospectively enrolled. Coregistered histopathological gross tumor volume (GTV-Histo) was used as standard of reference. PSMA-PET images were contoured on two ways: (1) manual contouring with PET scaling SUVmin-max: 0–10 was performed by three teams with different levels of experience. Team 1 repeated contouring at a different time point, resulting in n = 4 manual contours. (2) Semi-automatic contouring approaches using SUVmax thresholds of 20–50% were performed. Interobserver agreement was assessed for manual contouring by calculating the Dice Similarity Coefficient (DSC) and for all approaches sensitivity, specificity were calculated by dividing the prostate in each CT slice into four equal quadrants under consideration of histopathology as standard of reference.ResultsManual contouring yielded an excellent interobserver agreement with a median DSC of 0.90 (range 0.87–0.94). Volumes derived from scaling SUVmin-max 0–10 showed no statistically significant difference from GTV-Histo and high sensitivities (median 87%, range 84–90%) and specificities (median 96%, range 96–100%). GTVs using semi-automatic segmentation applying a threshold of 20–40% of SUVmax showed no significant difference in absolute volumes to GTV-Histo, GTV-SUV50% was significantly smaller. Best performing semi-automatic contour (GTV-SUV20%) achieved high sensitivity (median 93%) and specificity (median 96%). There was no statistically significant difference to SUVmin-max 0–10.ConclusionManual contouring with PET scaling SUVmin-max 0–10 and semi-automatic contouring applying a threshold of 20% of SUVmax achieved high sensitivities and very high specificities and are recommended for [18F]PSMA-1007 PET based focal therapy approaches. Providing high specificities, semi-automatic approaches applying thresholds of 30–40% of SUVmax are recommend for biopsy guidance.https://www.frontiersin.org/articles/10.3389/fonc.2020.600690/fullprimary prostate cancerfocal therapycontouringPSMA-PET/CThistopathology |